Similar articles

• [Beta-lactam antibiotics].

  Suárez C, Gudiol F. Suárez C, et al. Enferm Infecc Microbiol Clin. 2009 Feb;27(2):116-29. doi: 10.1016/j.eimc.2008.12.001. Epub 2009 Feb 15. Enferm Infecc Microbiol Clin. 2009. PMID: 19254642 Review. Spanish.
• β-Lactam and glycopeptide antibiotics: first and last line of defense?

  Jovetic S, Zhu Y, Marcone GL, Marinelli F, Tramper J. Jovetic S, et al. Trends Biotechnol. 2010 Dec;28(12):596-604. doi: 10.1016/j.tibtech.2010.09.004. Epub 2010 Oct 21. Trends Biotechnol. 2010. PMID: 20970210 Review.
• Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.

  Arguedas A, Cespedes J, Botet FA, Blumer J, Yogev R, Gesser R, Wang J, West J, Snyder T, Wimmer W; Protocol 036 Study Group. Arguedas A, et al. Int J Antimicrob Agents. 2009 Feb;33(2):163-7. doi: 10.1016/j.ijantimicag.2008.08.005. Epub 2008 Oct 21. Int J Antimicrob Agents. 2009. PMID: 18945594 Clinical Trial.
• Meta-analysis: ertapenem for complicated intra-abdominal infections.

  Falagas ME, Peppas G, Makris GC, Karageorgopoulos DE, Matthaiou DK. Falagas ME, et al. Aliment Pharmacol Ther. 2008 May;27(10):919-31. doi: 10.1111/j.1365-2036.2008.03642.x. Epub 2008 Feb 9. Aliment Pharmacol Ther. 2008. PMID: 18266994
• Part II. Introduction to the beta-lactam antibiotics.

  Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA. Cooper TW, et al. J Okla State Med Assoc. 2006 Oct;99(10):516-20. J Okla State Med Assoc. 2006. PMID: 17125105 Review. No abstract available.